Volume 12, Issue 1 (2-2014)                   IJRM 2014, 12(1): 15-0 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mansouri Torshizi M, Khalighi A R, Islam M F, Aram R, Sabouri E, Khalilifar H et al . Effect of human T-cell lymphotrophic virus type 1 (HTLV-1) in seropositive infertile women on intracytoplasmic sperm injection (ICSI) outcome. IJRM. 2014; 12 (1) :15-0
URL: http://journals.ssu.ac.ir/ijrmnew/article-1-477-en.html
1- Novin Infertility Treatment Center, Mashhad, Iran
2- Mashhad University of Medical Sciences, Mashhad, Iran
3- Novin Infertility Treatment Center, Mashhad, Iran , mahlafadavi@gmail.com
Abstract:   (494 Views)
Background: Human T-cell Lymphotrophic virus type 1 (HTLV-1) has infected more than 20 million people worldwide. Northeast of Iran, Mashhad, the capital of Razavi Khorasan Province, is endemic for HTLV-1 with a prevalence of 3% among general population.
Objective: We evaluated the ICSI outcome in our program for (HTLV-1) serodiscordant couples (SDCs) with the female infected in comparison with control group.
Materials and Methods: This study was performed between 2007 and 2011 in Novin Infertility Treatment Center (Mashhad, Iran). We examined 32 ICSI cycles of HTLV-1 infected women in comparison with an age matched control group (n=62). ICSI outcome was compared regarding fertilization rate (FR), embryo quality parameters, implantation rate (IR), clinical pregnancy rate (PR), and abortion rate (AR).
Results: Fertilization (p=0.15), implantation (p=0.33), and pregnancy rate (p=0.12) were similar between the groups. No difference was found regarding the number of transferred embryos (on day 2 or 3) and cryopreserved embryos, multiple pregnancies, or abortion rates between the groups.
Conclusion: Our results suggest that the embryo quality and ICSI outcome are not affected by HTLV-1 infection in serodiscordant couples. The major finding of this study is that the outcome of ICSI in HIV-I-infected patients and seronegative controls is similar.
Full-Text [PDF 235 kb]   (88 Downloads) |   |   Full-Text (HTML)  (50 Views)  
Type of Study: Original Article |

References
1. Gotuzzo E, Verdonck K. HTLV-1: clinical impact of a chronic infection. The infectious etiology of chronic diseases: defining the relationship, enhancing the research, and mitigating the effects: workshop summary book. 2004.
2. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-1 infectionand associated diseases. Oncogene 2005; 24: 6058-6068. [DOI:10.1038/sj.onc.1208968]
3. Vrielink H, Reesink HW. HTLV-I/II prevalence in different geographic locations. Transfus Med Rev 2004; 18: 46-57. [DOI:10.1016/j.tmrv.2003.10.004]
4. Hedayati-Moghaddam MR, Fathimoghadam F, Eftekharzadeh Mashhadi I, Soghandi L, Bidkhori HR. Epidemiology of HTLV-1 in Neyshabour, Northeast of Iran. Iran Red Crescent Med J 2011; 13: 424-427.
5. Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, et al. Harrison's principles of internal medicine. 17th Ed. New York: McGraw-Hill Medical Publishing Division; 2008.
6. Mandell GL, Bennett JE, Dolin R. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th Ed. 2010.
7. Safai B, Huang JL, Boeri E, Farid R, Raffat J, Schutzer P, et al. Prevalence of HTLV type I infection in Iran: a serological and genetic study. AIDS Res Hum Retroviruses 1996; 12: 1185-1190. [DOI:10.1089/aid.1996.12.1185]
8. Lal RB, Brodine SK, Coligan JE, Roberts CR. Differential antibody responsiveness to p19 gag results in serological discrimination between human T-lymphotropic virus type I and type II. J Med Virol 1991; 35: 232-236. [DOI:10.1002/jmv.1890350404]
9. Chen YM, Lee TH, Wiktor SZ, Shaw GM, Murphy EL, Blattner WA, et al. Type-specific antigens for serological discrimination of HTLV-I and HTLV-II infection. Lancet 1990; 336: 1153-1155. [DOI:10.1016/0140-6736(90)92769-E]
10. Beilke MA, Traina-Dorge V, England JD, Blanchard JL. Polymyositis, arthritis, and uveitis in a macaque experimentally infected with human T lymphotropic virus type I. Arthritis Rheum 1996; 39: 610-615. [DOI:10.1002/art.1780390410]
11. Glynn JR, Caraël M, Auvert B, Kahindo M, Chege J, Musonda R, et al. Why do young women have a much higher prevalence of HIV than young men? AIDS 2001; 15: S51-S60. [DOI:10.1097/00002030-200108004-00006]
12. Terriou P, Auquier V, Chabert-Orsini JM, Chinchole L, Cravello C, Giorgetti P, et al. Outcome of ICSI in HIV-1-infected women. Hum Reprod 2005; 20: 2838-2843. [DOI:10.1093/humrep/dei119]
13. Barreto Melo MA, Meseguer M, Bellver J, Remoh J, Pellicer A, Garrido N. Human immunodeficiency type-1 virus (HIV-1) infection in serodiscordant couples (SDCs) does not have an impact on embryo quality or intracytoplasmic sperm injection (ICSI) outcome. Fertil Steril 2008; 89: 141-149. [DOI:10.1016/j.fertnstert.2007.02.004]
14. Cooper TG, Noonan E, von Eckardstein S, Auger J, Baker HWG, Behre HM, et al. World Health Organization reference values for human semen characteristics. Hum Reprod Update 2010; 16: 231-245. [DOI:10.1093/humupd/dmp048]
15. Racowsky C, Stern JE, Gibbons WE, Behr B, Pomeroy KO, Biggers JD. National collection of embryo morphology data into Society for Assisted Reproductive Technology Clinic Outcomes Reporting System: associations among day 3 cell number, fragmentation and blastomere asymmetry, and live birth rate. Fertil Steril 2011; 95: 1985-1989. [DOI:10.1016/j.fertnstert.2011.02.009]
16. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-1 infection and associated diseases. Oncogene 2005; 24: 6058-6068. [DOI:10.1038/sj.onc.1208968]
17. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980; 77: 7415-7419. [DOI:10.1073/pnas.77.12.7415]
18. Manns A, Hisada M, La Grenade L. Human T-lymphotropic virus type I infection. Lancet 1999; 353: 1951-1958. [DOI:10.1016/S0140-6736(98)09460-4]
19. Fujino T, Nagata Y. HTLV-1 transmission from mother to child. J Reprod Immunol 2000; 47: 197-206. [DOI:10.1016/S0165-0378(00)00054-1]
20. Ho GYF, Kenrad N, Nomura AMY, Polk BF, Blattner WA. Markers of Health Status in an HTLV-1- Positive Cohort. Am J Epidemiol 1992; 136: 1349-1357. [DOI:10.1093/oxfordjournals.aje.a116447]
21. LaGrenade L, Hanchard B, Fletcher V, Cranston B, Blattner W. Infective dermatitis of Jamaican children: a marker for HTLV-1 infection. Lancet 1990; 336: 1345-1346. [DOI:10.1016/0140-6736(90)92896-P]
22. Sabouri AH, Usuku K, Hayashi D, Izumo S, Ohara Y, Osame M, et al. Impaired function of human T-lymphotropic virus type 1 (HTLV-1)- specific CD8+ T cells in HTLV-1-associated neurologic disease. Blood 2008; 112: 2411-2420. [DOI:10.1182/blood-2008-02-140335]
23. CDC (Centers for Disease Control and Prevention). Recommendations for counseling persons infected with human T-lymphotropic virus, types I and II. Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex for adults and adolescents infected with human immunodeficiency virus. MMWR 1993; 42: 1-13.
24. Benifla JL, Letur-Konïrsch H, Collin G, Devaux A, Kuttenn F, Madelenat P, et al. Safety of cryopreservation straws for human gametes or embryos: a preliminary study with human immunodeficiency virus-1. Hum Reprod 2000; 15: 2186-2189. [DOI:10.1093/humrep/15.10.2186]
25. Kushnir VA, Lewis W. Human immunodeficiency virus/acquired immunodeficiency syndrome and infertility: emerging problems in the era of highly active antiretrovirals. Fertil Steril 2011; 96: 546-553. [DOI:10.1016/j.fertnstert.2011.05.094]
26. Englert Y, Van Vooren JP, Place I, Liesnard C, Laruelle C, Delbaere A. ART in HIV-infected couples has the time come for a change of attitude? Hum Reprod 2001; 16: 1309-1315. [DOI:10.1093/humrep/16.7.1309]
27. Savasi V, Mandia L, Laoreti A, Cetin I. Reproductive assistance in HIV serodiscordant couples Hum. Hum Reprod Update 2013; 19: 136-150. [DOI:10.1093/humupd/dms046]
28. Vandermaelen A, Englert Y. Human immunodeficiency virus serodiscordant couples on highly active antiretroviral therapies with undetectable viral load: conception by unprotected sexual intercourse or by assisted reproduction techniques? Hum Reprod 2010; 25: 374-379. [DOI:10.1093/humrep/dep412]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


© 2020 All Rights Reserved | International Journal of Reproductive BioMedicine

Designed & Developed by : Yektaweb